“Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s102. doi:10.25251/skin.1.supp.101.